Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features

Cancer

Volumn 79, Issue 4, 1997, Pages 780-789

  Lee, Chyi Chia R ^a   Yamamoto, Shinji ^a   Morimura, Keiichirou ^a   Wanibuchi, Hideki ^a   Nishisaka, Nobuyasu ^a   Ikemoto, Shinichi ^a   Nakatani, Tatsuya ^a   Wada, Seiji ^a   Kishimoto, Taketoshi ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cell cycle; Cyclin D1; p53; proliferating cell nuclear antigen; transitional cell carcinoma; urinary bladder

Indexed keywords

CYCLIN D1; CYCLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CELL CYCLE; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CARCINOMA, TRANSITIONAL CELL; CELL NUCLEUS; CYCLIN D1; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0031054096     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970215)79:4<780::AID-CNCR15>3.0.CO;2-W     Document Type: Article

References (24)

1. Carrol PR. Urothelial carcinoma: cancers of the bladder, ureter, & renal pelvis. In: Tanagho EA, McAninch JW, editors. Smith's general urology. 14th edition. Norwalk, CT: Appleton & Lange, 1995:353-71.
2. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
3. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
4. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991;65:701-13.
5. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature 1991;350:512-5.
6. Motokura T, Arnold A. Cyclin D1 and oncogenesis. Curr Opin Genet Dev 1993;3:5-10.
7. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991;88:9638-42.
8. Wang TC, Cardiff RD, Zukerberg LR, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 (PRAD-I) transgenic mice. Nature 1994; 369:669-71.
9. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-9.
10. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJP. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-8.
11. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995;11:885-91.
12. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994;54:3107-10.
13. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WDJ, Cerny T, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996;73:294-300.
14. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87:6166-70.
15. Giannino DS, Murphy M, Ruaro EM, Lazarevic D, Levine AJ, Schneider C. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 1996;12:177-85.
16. Ohshima M, Fukushima S, Okamura T, Asamoto M, Okajima E, Washida H, et al. Histopathological analysis of 98 urinary bladder carcinoma cases by the serial section whole-organ approach. J Urol Pathol 1995;3:1-15.
17. Frierson HF, Gaffey MJ, Zukerberg LR, Arnold A, Williams ME. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod Pathol 1996;9:723-30.
18. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-14.
19. Lipponen PK, Eskelinen MJ. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 1992;66:171-6.
20. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993;90:9026-30.
21. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-9.
22. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WDJ, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995;11:1005-11.
23. Esrig D, Spruck CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993;143:1389-97.
24. Spruck CH III, Schmutte C, Yane AS, Cote R, Dubeau L, Nichols PW, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;54:784-8.